HANNAH PERRILLOUX: Open Payments
NPI 1497497275 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 19 payments from 12 companies in 2025. Trend: 2023 $632 · 2024 $494 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 5 | $189 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Olympus America Inc. | 1 | $51 |
| PFIZER INC. | 2 | $43 |
| UROGEN PHARMA, INC. | 1 | $40 |
| STERIS CORPORATION | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| 180 Medical, Inc. | 1 | $28 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $18 |
Products named: XYOSTED, GEMTESA, iTIND System, XTANDI, ZUSDURI, Uretero1, PLUVICTO, PROLARIS.
Industry payments across LA — which companies pay providers there.
